Latest Leverage News

Altech Batteries reveals Sodium-Nickel-Chloride (SNC) batteries achieve an exceptionally low failure rate of 0.6-1.5% over 15+ years in harsh South African conditions, significantly outperforming lithium-ion and lead-acid alternatives.

National Australia Bank reported a modest rise in underlying profit for FY25, driven by robust revenue and volume growth in the second half, alongside continued technology modernization and sustainability progress.

Immuron Limited has secured FDA approval for its IMM-529 Investigational New Drug application, clearing the way for a Phase 2 clinical trial targeting Clostridioides difficile infection. This milestone marks a significant step forward for a novel oral antibody therapy addressing a critical infectious disease with high recurrence rates.

Eagle Mountain Mining has received a non-binding indicative offer from Japan’s Nittetsu Mining to form a joint venture, injecting up to US$20 million to advance the Oracle Ridge copper project towards production by 2030.

Verbrec Limited is streamlining its business by selling its Competency Training division for $11.5 million and acquiring Alliance Automation for $5.5 million, significantly boosting its digital and automation capabilities.

Verbrec Limited has agreed to acquire Alliance Automation for $5.5 million, significantly expanding its automation and digital capabilities while adding over $60 million in annual revenue.

Mesoblast is set to meet the FDA in December to discuss compelling Phase 3 data showing its cell therapy rexlemestrocel-L may significantly reduce opioid use in chronic low back pain patients. This meeting could mark a pivotal step in addressing the US opioid crisis through innovative regenerative medicine.

EnergyX’s share price hike to US$11 signals renewed investor confidence and a lithium market rebound, increasing Pantera Lithium’s holding value by A$5.4 million.

Impact Minerals is reigniting exploration at its vast Broken Hill project in NSW, leveraging rising metal prices and a proprietary multi-metal ratio to uncover high-grade platinum group metals and base metals.

Peel Mining Limited reveals a robust high-grade resource base and ongoing exploration in the Cobar Basin, positioning itself for growth amid a dynamic regional mining landscape.

Artrya secures participation from Mass General Brigham, a leading U.S. cardiovascular research center, in its pivotal SAPPHIRE Study launching in early 2026. This collaboration aims to validate Artrya’s AI-powered Salix platform for earlier and more effective coronary artery disease detection.

Tryptamine Therapeutics has raised $6.1 million to fast-track clinical development of its IV-infused psilocin drug TRP-8803, targeting binge eating disorder and other neuropsychiatric conditions.